A peptidomimetic that specifically inhibits human leukocyte antigen DRB1*0401-restricted T cell proliferation

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 2, 1997, Pages 663-669

  Woulfe, Susan L ^a   Bono, Christine P ^a   Zacheis, Michelle L ^a   Welply, Joseph K ^a   Kirschmann, Dawn A ^a,b   Baudino, Troy A ^a   Wang, Yang ^a   Stone, Deborah A ^a   Hanson, Gunnar J ^a   Vuletich, Jennifer L ^a   Bedell, Louis J ^a   Schwartz, Benjamin D ^a   Howard, Susan C ^a  

^a PFIZER INC   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HA 307 319; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE DERIVATIVE; SC 67655; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY COMBINING SITE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG DESIGN; DRUG THERAPY; ETIOLOGY; HLA SYSTEM; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

BINDING SITES; CELL DIVISION; CELL LINE; HLA-DR ANTIGENS; HUMANS; OLIGOPEPTIDES; T-LYMPHOCYTES;

EID: 8244240431     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. ABBAS, A. K., LICHTMAN, A. H. AND POBER, J. S.: Cellular and Molecular Immunology, W. B. Saunders Co., Philadelphia, 1991.
2. ADORINI, L., APPELLA, E., CORIA, G., CARDINAUZ, F. AND NAGY, Z. A.: Competition for antigen presentation in living cells involves exchange of peptides bound by class II MHC molecules. Nature (Lond.) 342: 800-803, 1989.
3. ADORINI, L., MORENO, J., MOMBURG, F., HAMMERLING, G. J., QUÉRY. J-C., VALLI, M. A. AND FUCHS, S.: Exogneous peptides compete for the presentation of endogenous antigens to major histocompatibility complex class II-restricted T cells. J. Exp. Med. 174: 945-948, 1991.
4. ADORINI, L. AND NAGY, Z. A.: Peptide competition for antigen presentation. Immunol. Today 11: 21-24, 1990.
5. BARBER, L. D. AND PARHAM, P.: Peptide binding to major histocompatibility complex molecules. Annu. Rev. Cell. Biol. 9: 163-206, 1993.
6. BRODSKY, F. M. AND GUAGLIARDI, L. E.: The cell biology of antigen processing and presentation. Annu. Rev. Immunol. 9: 707-744, 1991.
7. CHICZ, R. M., URBAN, R. G., GORGA, J. C., VIGNALI, D. A. A., LANE, W. S. AND STROMINGER, J. L.: Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178: 27-47, 1993.
8. DEKROON, A. I. P. M. AND MCCONNELL, H. M.: Kinetics and specificity of peptide-MHC class II complex displacement reactions. J. Immunol. 152: 609-619, 1994.
9. DEMOTZ, S., GREY, H. M. AND SETTE, A.: The minimal number of class II MHC-antigen complexes needed for T cell activation. Science (Wash. DC) 249: 1028-1030, 1990.
10. Fox, R. I. AND KANG, H.-I.: Mechanism of action of antimalarial drugs: Inhibition of antigen processing and presentation. Lupus 2: S9-S12, 1993.
11. FRIDKIS-HARELI, M., TEITELBAUM, D., GUREVICH, E., PECHT, I., BRAUTBAR, C., KWON, O. J., BRENNER, T., ARNON, R. AND SELA, M.: Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells: Specificity and promiscuity. Proc. Natl. Acad. Sci. U.S.A. 91: 4872-4876, 1994.
12. FRUMESTO, G., DE TOTERO, D., FERRARA, G. B., CHERSI, A. AND PERNIS, B.: Cellular mechanisms of exogenous peptide binding to HLA class II molecules in B cells. Cell. Immunol. 155: 1-10, 1994.
13. FU, X.-T., BONO, C. P., WOULFE, S. L., SWEARINGEN, C., SUMMERS, N. L., SINIGAGLIA, F., SETTE, A., SCHWARTZ, B. D. AND KARR, R. W.: Pocket 4 of the HLA-DR (α,β1*0401) molecule is a major determinant ofT cell recognition of peptide. J. Exp. Med. 181: 915-926, 1995.
14. + T cell recognition of peptides containing two or more cysteine residues. J. Immunol. 155: 1575-1587, 1995.
15. GUÉRY, J-C., NEAGU, M., RODRIGUEZ-TARDUCHY, G. AND ADORINI, L.: Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. II. Preventive inhibition of primary and secondary in vivo antibody responses. J. Exp. Med. 177: 1461-1468, 1993.
16. GUÉRY, J.-C., SETTE, A., LEIGHTON, J., DRAGOMIR, A. AND ADORINI, L.: Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation. J. Exp. Med. 175: 1345-1352, 1992.
17. HAMMER, J., VALSASNINI, P., TOLBA, K., BOLIN, D., HIGELIN, J., TAKACS, B. AND SINIGAGLIA, F.: Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 74: 197-203, 1993.
18. HANSON, G. J., VULETICH, J. L., BEDELL, L. J., BONO, C. P., HOWARD, S. C., WELPLY, J. K., WOULFE, S. L. AND ZACHEIS, M. L.: Design of MHC II (DR4) ligands using conformationally restricted imino acids at p3 and p5. Bioorg. Med. Chem. Lett. 6: 1931-1936, 1996.
19. HARDING, C. V. AND UNANUE, E. R.: Quantitation of antigen-presenting cell MHC class Il/peptide complexes necessarv for T-cell stimulation. Nature (Lond.) 346: 574-576, 1990.
20. HURTENBACH, U., LIER, E., ADORINI, L. AND NAGY, Z. A.: Prevention of autoimmune diabetes in non-obese diabetic mice by treatment with a class II major histocompatibility complex-blocking peptide. J. Exp. Med. 177: 1499-1504, 1993.
21. KIRSCHMANN, D. A., DUFFIN, K. L., SMITH, C. E., WELPLY, J. K., HOWARD, S. C., SCHWARTZ, B. D. AND WOULFE, S. L.: Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA DR alleles. J. Immunol. 155: 5655-5662, 1995.
22. LIN, Y.-Z., YAO, S. Y., VEACH, R. A., TORGERSON, T. R. AND HAWIGER, J.: Inhibition of nuclear translocation of transcription factor NF-κB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270: 14255-14258, 1995.
23. MARSH, S. AND BODMER, G.: HLA class II nucleotide sequences. Hum. Immunol. 35: 1-17, 1992.
24. MATSUMOTO, Y., OHSAKO, M., TAKADATE, A. AND GOTO, S.: Reduction of erythrocyte membrane permeability and protein binding of low-molecular-weight drugs following glycoside derivitization. J. Pharm. Sci. 82: 399-403, 1993.
25. MCKINNEY, J. S., FU, X.-T., SWEARINGEN, C., KLOHE, E. AND KARR, R. W.: Individual effects of the DR11-variable β chain residues 67, 71, and 86 upon DR(α,β1*1101)-restricted, peptide specific T cell proliferation. J. Immunol. 153: 5564-5571, 1994.
26. OHSAKO, M., MATSUMOTO, Y. AND GOTO, S.: Transport of aspirin and its metabolites through human erythrocyte membrane. Biol. Pharm. Bull. 16: 154-157, 1993.
27. O'SULLIVAN, D., SIDNEY, J., APPELLA, E., WALKER, L., PHILLIPS, L., COLÓN. S. M., MILES, C., CHESNUT, R. W. AND SETTE, A.: Characterization of the specificity of peptide binding to four DR haplotypes. J. Immunol. 145: 1799-1808, 1990.
28. SETTE, A., SIDNEY, J., OSEROFF, C., DEL GUERCIO, M.-F., SOUTHWOOD, S., ARRHENIUS, T., POWELL, M. F., COLON, S. M., GAETA, F. C. A. AND GREY, H. M.: HLA DR4 Dw4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J. Immunol. 151: 3163-3170, 1993.
29. SMILEK, D. E., LOCK, C. B. AND MCDEVITT, H. O.: Antigen recognition and peptide-mediated immunotherapy in autoimmune disease. Immunol. Rev. 118: 37-71, 1990.
30. SMITH, S. C. AND ALLEN, P. M.: Myosin-induced acute myocarditis is a T cell-mediated disease. J. Immunol. 147: 2141-2147, 1991.
31. WAUBEN, M. H. M., JOOSTEN, I., SCHLIEF, A., VAN DER ZEE, R., BOOG, C. J. P. AND VAN EDEN, W.: Inhibition of experimental autoimmune encephalomyelitis by MHC class II binding competitor peptides depends on the relative MHC binding affinity of the disease-inducing peptide. J. Immunol. 152: 4211-4219, 1994.
32. WELLS, G. AND TUGWELL, P.: Cyclosporin A in rheumatoid arthritis: Overview of efficacy. Br. J. Rheumatol. 32: 51-56, 1993.
33. WINCHESTER, R.: The molecular basis of susceptibility to rheumatoid arthritis. Adv. Immunol. 56: 389-466, 1994.
34. WOULFE, S. L., BONO, C. P., ZACHEIS, M. L., KIRSCHMANN, D. A., BAUDINO, T. A., KARR, R. W., SWEARINGEN, C. AND SCHWARTZ, B. D.: Negatively charged residues interacting with the p4 pocket confer binding specificity to DRB1*0401. Arthritis Rheum. 38: 1744-1753, 1995.
35. ZIEGLER, H. K AND UNANUE, E. R.: Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc. Natl. Acad. Sci. U.S.A. 79: 175-178, 1982.